- CEO
- Bang Lao Liu
- Full Time Employees
- 635
- Sector
- Producer manufacturing
- Industry
- Miscellaneous manufacturing
- Address
- Yichang China
- IPO Date
- Dec 6, 2021
- Business
- Hubei Huaqiang High-Tech Co., Ltd. is a China-based manufacturing enterprise primarily engaged in the research, development, production, and sale of pharmaceutical packaging materials, medical devices, and special chemical, biological, radiological, and nuclear (CBRN) protective equipment. Founded in 2001 and headquartered in Yichang, Hubei Province, the company operates as a key specialized industrial subsidiary under China South Industries Group Corporation (CSGC), serving clients across defense, clinical healthcare, and commercial pharmaceutical sectors both domestically and internationally.
The company operates through three principal business segments: Pharmaceutical Packaging Materials, Medical Devices, and Special Protective Equipment. Its Pharmaceutical Packaging Materials portfolio comprises halobutyl medicinal rubber stoppers for freeze-dried formulations, sterile powder injections, large-volume parenterals, and vacuum blood collection tubes; high-compatibility film-coated rubber stoppers; multi-layer co-extruded infusion films; and aluminum-plastic combination closure seals. The Medical Devices segment manufactures surgical and particulate protective masks; disposable medical protective coveralls; rubber plungers and tip caps for pre-filled syringes; and precision drug delivery assemblies. The Special Protective Equipment segment develops and supplies individual protective systems, including military and industrial gas masks, breathable chemical protective suits, protective hoods, and specialized protective boots; as well as collective filtration systems, including high-efficiency filter absorbers, air purification ventilation units, and integrated protective installations for civil defense and specialized defense facilities.
In recent developments, Hubei Huaqiang High-Tech Co., Ltd. has expanded its operational footprint through the phased commissioning of its New Drug Delivery Devices and Packaging Materials R&D and Industrialization Project, constructing automated, cleanroom-compliant production lines to increase manufacturing capacity for high-barrier coated stoppers and prefillable syringe components. The company has integrated automated vulcanization robotics, robotic trimming systems, and automated optical inspection equipment developed in collaboration with the Institute of Automation of the Chinese Academy of Sciences to accelerate intelligent manufacturing across its packaging operations. Furthermore, the company has established a Public Service Platform for Pharmaceutical Excipients and Packaging Materials Testing and Evaluation to deliver technical validation and regulatory compliance services. Strategically, the company has expanded commercial supply agreements with major pharmaceutical enterprises, including Sinopharm, Guangzhou Pharmaceutical Holdings, Hisun Pharmaceutical, and Luye Pharma, focusing product development on high-end container closure solutions for biopharmaceuticals and advanced injectable therapeutics.